InnoPharmax Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	1,194	1,807	1,748	1,653	1,016	1,509
Market Cap Growth	-47.14%	3.38%	5.76%	62.70%	-32.67%	15.28%
Enterprise Value	942	1,583	1,648	1,475	897	1,303
Last Close Price	11.10	16.69	16.14	17.17	11.38	16.93
Forward PE	-	8.65	8.65	8.65	8.65	8.65
PS Ratio	17.70	26.20	54.13	35.88	34.87	31.40
PB Ratio	2.25	4.31	2.90	3.48	2.36	2.84
P/TBV Ratio	2.28	4.37	2.93	3.53	2.41	2.89
EV/Sales Ratio	13.96	22.95	51.02	32.03	30.78	27.11
Debt / Equity Ratio	0.02	0.03	0.03	0.05	0.09	0.01
Net Debt / Equity Ratio	-0.48	-0.32	-0.44	-0.25	-0.14	-0.34
Net Debt / EBITDA Ratio	1.32	0.80	2.83	1.90	0.66	2.62
Net Debt / FCF Ratio	1.67	1.01	3.46	2.42	0.59	3.53
Asset Turnover	0.12	0.13	0.06	0.09	0.06	0.08
Inventory Turnover	3.07	3.54	0.53	1.02	1.27	1.24
Quick Ratio	6.14	2.99	9.74	4.34	2.48	13.45
Current Ratio	6.42	3.52	10.90	5.57	3.50	14.72
Return on Equity (ROE)	-37.62%	-36.09%	-18.41%	-15.63%	-21.44%	-18.54%
Return on Assets (ROA)	-20.48%	-19.48%	-10.37%	-8.00%	-11.16%	-7.52%
Return on Capital Employed (ROCE)	-35.90%	-41.00%	-15.90%	-13.20%	-20.70%	-13.70%
Earnings Yield	-17.05%	-10.20%	-5.68%	-4.29%	-10.16%	-6.16%
FCF Yield	-12.65%	-7.44%	-4.39%	-2.96%	-9.85%	-3.41%
Buyback Yield / Dilution	-8.37%	-10.36%	-5.83%	-6.20%	-0.31%	-12.92%